This handout is for eisenmenger syndrome (chronic achd — pah-chd severe end). Your care team identified this based on: central cyanosis / low spo2 with congenital shunt + severe pah.
Other reasons your team may use this plan: secondary erythrocytosis (elevated hb/hct) with cyanotic chd; exertional dyspnea / syncope in shunt patient; hemoptysis (pulmonary hemorrhage risk).
Take these medications exactly as prescribed. Do not stop or change a dose without talking to your provider.
| Medication | Starting dose | How | When | What it does |
|---|---|---|---|---|
| do NOT close the shunt; pregnancy CONTRAINDICATED (contraception counseling); avoid routine phlebotomy/dehydration/high-altitude/iatrogenic air emboli | — | — | — | Shunt closure is fatal; pregnancy carries ~30–50% maternal mortality; routine phlebotomy worsens iron deficiency/hyperviscosity (2020 ESC ACHD; 2022 ESC/ERS PH) |
Plan: Eisenmenger — goal-directed PAH therapy + absolute-rule guardrails (2018 AHA/ACC ACHD; 2020 ESC ACHD; 2022 ESC/ERS PH)
Contact your care team if any of the following happen:
Call 911 or go to the nearest emergency room right away if you have:
Lifelong PAH-ACHD care; contraception + pregnancy-contraindication counseling; non-cardiac-surgery precautions
Guideline: 2018 AHA/ACC Adult Congenital Heart Disease Guideline (Stout) + 2020 ESC Adult Congenital Heart Disease Guideline (Baumgartner); 2022 ESC/ERS PH + BREATHE-5